Testosterone undecanoate (Andriol Testocaps) cap 40 mg: Discontinuation
Merck Sharpe & Dohme is discontinuing the supply of testosterone undecanoate (Andriol Testocaps) cap 40 mg. Pharmac has listed an alternative brand.
New brand listed
Pharmac has secured an alternative supply of testosterone undecanoate 40mg capsules. The new brand is not Medsafe-approved and will be listed as a section 29 medicine. It will be listed with wastage rules applied.
Listed from 1 August 2022:
- Chemical: Testosterone undecanoate
- Presentation: 40mg capsule
- Pharmacode: 2636840
- Brand: Steril-Gene
- Pack size: 100
- Subsidy and price (ex-man, ex-GST): $35.00
Prescribing and supplying a medicine under section 29
Section 29 of the Medicines Act allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – e.g., doctors.
We know supplying a medicine under section 29 is not ideal. In this case, however, the alternative would be for patients to have no testosterone undecanoate.
We apologise for any inconvenience this causes.
Information for pharmacists
RxOne users: The changes will be automatically updated by RxOne from the effective date.
TONIQ users: the changes will automatically be updated in Toniq medicine databases from the effective date.
Please note: Ministry of Health Sector Operations Group will be able to process claims in August 2022 in the normal claim cycle.
Who to contact
If you have questions about supply, contact your wholesaler.
If you have questions about funding for testosterone undecanoate, email us on firstname.lastname@example.org